Expert bioanalytical services

What do all therapies under development have in common?

Whether in the discovery, pre-clinical or clinical stage, they all need robust and reliable biomarker monitoring tools to track and characterize their biological effect.

Your Challenge

Monitoring biomarkers is a powerful tool to objectively measure the efficacy of a drug, predict its safety, document its mechanism of action and potential impact on the immune system. With decades of expertise in biomarker analysis, PK/PD, and immunogenicity testing, Active Biomarkers transforms your precious and unique clinical samples into reliable data to drive your decisions in the development of your innovative therapies.

Our Strengths
Our Approach


Very early in the discussions, our experts are involved in order to make sure that we get a good understanding of your needs and offer the most appropriate analytical solutions for your project.

ContACT for support

Chess game

With decades of experience in the development, optimization, and validation of custom cell-based and immune-assays, we can either develop methods from scratch, transfer them from a reference laboratory, optimize them, and, depending on their intended use, qualify or validate them for subsequent routine applications.

Sample management

We provide full technical support from sample preparation and cryopreservation, relying on standardized procedures, to storage. We work with trusted partners worldwide. We can provide technical and quality support for the evaluation and, if needed, training of laboratories involved in sample preparation.
Because clinical samples are unique, our freezers and Nitrogen tanks are 24/7 monitored.

Data safety

Testing results are absolutely central for your projects. We take extra care to fully track, secure and warranty the total confidentiality and security of your data during the course and after completion of your project.

Quality level

Quality is not an act; it’s a habit! (Aristotle)

Active Biomarkers is certified according to ISO 9001 Standards since its inception. In addition to ISO standards, our QMS is based on Good Clinical Laboratory Practices. We always implement the level of quality corresponding to your needs.


Learn more


Active Biomarkers has developed strong expertise in two main therapeutic areas: Immune-related disorders (Infectious, Inflammatory, Auto-Immune diseases, and Immuno-Oncology) and Neurological disorders.

We support pre-clinical and clinical studies, evaluating the safety, efficacy, and mode of action (MOA) of (Immuno)therapies through PK/PD, immunogenicity, biomarker analysis. Active Biomarkers has been supporting the development of innovative immunotherapies, including but not limited to antibody-based therapies (e.g., mAbs, Bispecific T cell Engagers, etc.), personalized neoantigen vaccines, CAR-T cells, or oncolytic virotherapies.


In order to provide you with bioanalytical solutions fitting your needs (soluble or cell-based biomarkers, multiparametric, ultrasensitivity) and constraints (sample volume, turn-around-time), Active Biomarkers relies on a wide range of technological platforms.

Our latest newsletters

  • January 24, 2022

Happy New Year from Active Biomarkers

A New Year Is starting!

One year back we were all hoping to be "back to normal" thanks to the advent of the vaccines. The January 2022 picture reminds us that the fight against COVID-19 is not over yet.

In these troubled times, being able to rely on a trusted partner is more critical than ever to overcome uncertainties and secure your research programs.

Easier said than done!

Active Biomarkers's team has proven all through 2021 its resilience and reliability. Here is how!
0 day of closing for the second year consecutively thanks to an evolutive business contingency plan and to the strong commitment of our team

1 relocation in brand new private facilities optimized to meet the highest regulatory standards

2 quality certificates in our new site (ISO 9001:2015 and GCLP)

3 new technologies installed, validated, and running to continue offering the latest innovations to your projects (Gyros xPloreTM, Novocyte QuanteonTM 20-color flow cytometer, Simoa HD-X AnalyzerTM)

78 studies supported during the year

1,100 sqm facilities to double our capacities

700,000 data points generated and analyzed

But nothing of this would have been possible without your continued trust and support!

We wish you all an exciting, successful and above all, beyond-COVID New Year!

  • November 15, 2021

Need to track circulating neurological biomarkers?

For clinical monitoring, patient stratification, documenting target engagement, leverage our ULTRASENSTITIVE and MULTIPLEX assays.

Click here to learn more

Subscribe to our newsletter